Literature DB >> 31908733

Microbiome and Schizophrenia.

Shahin Akhondzadeh1.   

Abstract

Entities:  

Year:  2019        PMID: 31908733      PMCID: PMC6925402     

Source DB:  PubMed          Journal:  Avicenna J Med Biotechnol        ISSN: 2008-2835


× No keyword cloud information.
Schizophrenia is a debilitating psychiatric disorder that contributes to a large cascade of emotional, occupational, and cognitive impairments. Treatment involves combination of psychosocial rehabilitation and pharmacotherapy. In most cases, chronic antipsychotic therapy is required to treat symptoms, avoid relapse and attenuate episode recurrence 1–3. Despite the growing number of pharmacologic agents for the treatment of schizophrenia, many patients do not adequately benefit from or tolerate currently available antipsychotics 1–3. Existing typical and atypical antipsychotic medications are relatively equally effective in treating what are known as the positive symptoms of schizophrenia. What has been prominently lacking, however, is an agent that also treats the negative symptoms as well as substantial cognitive impairment 1–3. Despite growing numbers of antipsychotic drugs for the treatment of schizophrenia, the management of this disorder remains to be a major challenge. Therefore, there is a need to find new strategies to improve treatment plans for schizophrenia patients. New studies have found that people with schizophrenia have differences in their gut biomes compared to people without the mental disorder 4,5. The researchers found a smaller subset of bacteria that were clearly different between schizophrenia patients and those without the disorder. They report that when they introduced samples of the subset from the schizophrenia patients into the biomes of healthy mice, the mice displayed behavior changes 6,7. The researchers claim that their results show that people with schizophrenia have differences in their gut biomes and that those differences may be associated with schizophrenia symptoms. They suggest that certain bacteria in the biome may be associated with schizophrenia-related symptoms due to interactions with microbiota gut-brain amino acids, and possibly lipid metabolic pathways. In conclusion, researchers have started to find interesting links between the naturally occurring bacteria that live in our guts, and things we’ve traditionally attributed to the brain. Things like our mood, feelings, and even thoughts 8.
  8 in total

1.  Schizophrenia and the microbiome: Time to focus on the impact of antipsychotic treatment on the gut microbiota.

Authors:  Timothy G Dinan; John F Cryan
Journal:  World J Biol Psychiatry       Date:  2018-12       Impact factor: 4.132

Review 2.  The microbiome, immunity, and schizophrenia and bipolar disorder.

Authors:  Faith Dickerson; Emily Severance; Robert Yolken
Journal:  Brain Behav Immun       Date:  2016-12-18       Impact factor: 7.217

3.  The 5-HT hypothesis of schizophrenia.

Authors:  S Akhondzadeh
Journal:  IDrugs       Date:  2001-03

4.  The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.

Authors:  Seyed-Hesameddin Abbasi; Haleh Behpournia; Aboulfazl Ghoreshi; Bahman Salehi; Maedeh Raznahan; Shams-Ali Rezazadeh; Farzin Rezaei; Shahin Akhondzadeh
Journal:  Schizophr Res       Date:  2009-12-02       Impact factor: 4.939

5.  Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.

Authors:  Alireza Ghajar; Faezeh Gholamian; Maryam Tabatabei-Motlagh; Mohsen Afarideh; Farzin Rezaei; Maryam Ghazizadeh-Hashemi; Shahin Akhondzadeh
Journal:  Hum Psychopharmacol       Date:  2018-06-14       Impact factor: 1.672

6.  The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice.

Authors:  Peng Zheng; Benhua Zeng; Meiling Liu; Jianjun Chen; Junxi Pan; Yu Han; Yiyun Liu; Ke Cheng; Chanjuan Zhou; Haiyang Wang; Xinyu Zhou; Siwen Gui; Seth W Perry; Ma-Li Wong; Julio Licinio; Hong Wei; Peng Xie
Journal:  Sci Adv       Date:  2019-02-06       Impact factor: 14.136

Review 7.  From Infection to the Microbiome: An Evolving Role of Microbes in Schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Curr Top Behav Neurosci       Date:  2020

8.  The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review.

Authors:  Alessandro Cuomo; Giuseppe Maina; Gianluca Rosso; Bruno Beccarini Crescenzi; Simone Bolognesi; Angela Di Muro; Nicola Giordano; Arianna Goracci; Stephen M Neal; Maria Nitti; Fulvio Pieraccini; Andrea Fagiolini
Journal:  Front Pharmacol       Date:  2018-10-15       Impact factor: 5.810

  8 in total
  2 in total

1.  Maternal immune activation alters adult behavior, intestinal integrity, gut microbiota and the gut inflammation.

Authors:  Wenqiang Li; Mengxue Chen; Xia Feng; Meng Song; Minglong Shao; Yongfeng Yang; Luwen Zhang; Qing Liu; Luxian Lv; Xi Su
Journal:  Brain Behav       Date:  2021-04-01       Impact factor: 2.708

Review 2.  d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia.

Authors:  Yu-Jung Cheng; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.